Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity 2024-11-22 12:14
1